Arivin Therapeutics
Helsinki-based Arivin Therapeutics is a biotechnology spin-off company from Aalto University and the University of Helsinki. It is involved in developing therapies to address drug-resistant bacterial infections.
Arivin Therapeutics has raised €3.0M across 1 funding round from 4 investors, most recently a Seed round in Sep 2025. Based in Helsinki, Finland; active in Healthtech. Data as of 28 Oct 2026.
Helsinki, Finlandarivintx.com ↗
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
4
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearArivin Therapeutics — funding by year — interactive chart.
Data table
| Arivin Therapeutics — funding by year | |
|---|---|
| 2025 | €3.0M |
Signals
High confidenceRaise-next likelihood62
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-02 | Seed | €3.0M | Angel Investors,Business Finland,Michiel Seerden,Private Investors | View deal → |
Investors
4Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData